
Biotechnology • Pharmaceuticals
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company translating insights from human genetics into the development of precision therapies for central nervous system (CNS) disorders, with a strong focus on genetic epilepsies and neuronal excitation–inhibition imbalance. The company uses genetics-driven target selection, translational tools, patient-guided development, and efficient clinical strategies to advance multiple clinical- and early-stage programs aimed at delivering high-impact treatments for patients with complex brain disorders.
51 - 200 employees
🧬 Biotechnology
💊 Pharmaceuticals
October 24
Director/Sr Director of Accounting overseeing monthly and quarterly financial close processes. Ensuring compliance with internal controls and SEC reporting within a biotech company.
October 24
Medical Writer supporting clinical development programs at Praxis. Collaborating on clinical and regulatory documents for CNS disorders.